Citations 1
A phase Ib/II study of cancer stem cell inhibitor BBI608 administered with panitumumab in KRAS wild-type (wt) patients (pts) with metastatic colorectal cancer (mCRC) following progression on anti-EGFR therapy.
Ciombor, Kristen K. , Edenfield, William J. , O’Dwyer, Peter J. , Becerra, Carlos , Larson, Tim , Manoharan, Divya , Li, Wei , Borodyansky, Laura, Li, Chiang, Hubbard, Joleen M. , Larson, Tim, Spira, Alexander I. , Grothey, Axel , Manoharan, Divya, Li, Youzhi , Bekaii‐Saab, Tanios
Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3617-3617
